Seres Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Seres Therapeutics, Inc. (MCRB) reported Increase (Decrease) in Accounts Receivable of $117.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $41.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $76.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$194.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $351.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $157.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- Seres Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $117.00K 10-Q · filed 2026-08-05 | -$77.00K derived: sum of 3 quarters · filed 2026-08-05 | $274.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $76.00K 10-Q · filed 2026-05-05 | -$118.00K derived: sum of 2 quarters · filed 2026-05-05 | $233.00K derived: sum of 3 quarters · filed 2026-05-05 | $233.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $157.00K derived: sum of 2 quarters · filed 2026-03-12 | $157.00K derived: sum of 3 quarters · filed 2026-08-05 | $157.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $351.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $351.00K derived: sum of 2 quarters · filed 2026-08-05 | $351.00K 10-Q · filed 2025-11-05 | $351.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $0.00 derived: sum of 3 quarters · filed 2024-03-05 | $0.00 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | -$1.25M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | -$1.25M derived: sum of 3 quarters · filed 2024-03-05 | -$1.25M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | -$1.25M derived: sum of 2 quarters · filed 2024-03-05 | -$1.25M derived: sum of 3 quarters · filed 2024-03-05 | -$2.60M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$1.25M derived: sum of 2 quarters · filed 2024-03-05 | -$2.60M derived: sum of 3 quarters · filed 2024-03-05 | -$9.39M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.35M derived: sum of 2 quarters · filed 2022-11-02 | -$8.14M 10-Q · filed 2022-11-02 | -$2.14M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$8.14M 10-Q · filed 2022-08-03 | -$2.14M derived: sum of 3 quarters · filed 2023-03-07 | -$1.68M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | -$6.78M 10-Q · filed 2022-05-04 | -$789.00K derived: sum of 2 quarters · filed 2023-03-07 | -$325.00K derived: sum of 3 quarters · filed 2023-03-07 | $582.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $6.46M derived: sum of 2 quarters · filed 2023-03-07 | $7.37M derived: sum of 3 quarters · filed 2023-03-07 | $7.60M 10-K · filed 2023-03-07 |
| 2020-09-30 | $464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.37M derived: sum of 2 quarters · filed 2021-11-10 | $1.61M 10-Q · filed 2021-11-10 | $1.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $907.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.14M 10-Q · filed 2021-08-03 | $1.21M derived: sum of 3 quarters · filed 2022-03-01 | $1.32M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $237.00K 10-Q · filed 2021-05-04 | $305.00K derived: sum of 2 quarters · filed 2022-03-01 | $418.00K derived: sum of 3 quarters · filed 2022-03-01 | -$4.64M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $181.00K derived: sum of 2 quarters · filed 2022-03-01 | -$4.88M derived: sum of 3 quarters · filed 2022-03-01 | $1.78M 10-K · filed 2022-03-01 |
| 2019-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$4.95M derived: sum of 2 quarters · filed 2020-11-09 | $1.72M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$5.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | $1.60M 10-Q · filed 2020-07-28 | ||
| 2019-03-31 | $6.67M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |